Cargando…

Current and Future Applications of Toxicogenomics: Results Summary of a Survey from the HESI Genomics State of Science Subcommittee

BACKGROUND: In spite of the application of toxicogenomic (TGx) data to the field of toxicology for the past 10 years, the broad implementation and full impact of TGx for chemical and drug evaluation to improve decision making within organizations and by policy makers has not been achieved. OBJECTIVE...

Descripción completa

Detalles Bibliográficos
Autores principales: Pettit, Syril, des Etages, Shelley Ann, Mylecraine, Louis, Snyder, Ronald, Fostel, Jennifer, Dunn, Robert T., Haymes, Kenneth, Duval, Manuel, Stevens, James, Afshari, Cynthia, Vickers, Alison
Formato: Texto
Lenguaje:English
Publicado: National Institute of Environmental Health Sciences 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920921/
https://www.ncbi.nlm.nih.gov/pubmed/20100679
http://dx.doi.org/10.1289/ehp.0901501
_version_ 1782185333693087744
author Pettit, Syril
des Etages, Shelley Ann
Mylecraine, Louis
Snyder, Ronald
Fostel, Jennifer
Dunn, Robert T.
Haymes, Kenneth
Duval, Manuel
Stevens, James
Afshari, Cynthia
Vickers, Alison
author_facet Pettit, Syril
des Etages, Shelley Ann
Mylecraine, Louis
Snyder, Ronald
Fostel, Jennifer
Dunn, Robert T.
Haymes, Kenneth
Duval, Manuel
Stevens, James
Afshari, Cynthia
Vickers, Alison
author_sort Pettit, Syril
collection PubMed
description BACKGROUND: In spite of the application of toxicogenomic (TGx) data to the field of toxicology for the past 10 years, the broad implementation and full impact of TGx for chemical and drug evaluation to improve decision making within organizations and by policy makers has not been achieved. OBJECTIVES: The goal of the Health and Environmental Sciences Institute (HESI) Committee on the Application of Genomics to Mechanism-based Risk Assessment was to construct and summarize a multisector survey, addressing key issues and perspectives on the current and future practical uses and challenges of implementing TGx data to facilitate discussions for decision making within organizations and by policy makers. METHODS: An online survey to probe the current status and future challenges facing the field of TGx for drug and chemical evaluation in experimental and nonclinical models was taken by scientists and scientific decision/policy makers actively engaged in the field of TGx within industrial, academic, and regulatory sectors of the United States, Europe, and Japan. For this survey, TGx refers specifically to the analysis of gene expression responses to evaluate xenobiotic exposure in experimental and preclinical models. RESULTS: The survey results are summarized from questions covering broad areas including technology used, organizational capacity and resource allocation, experimental approaches, data storage and exchange, perceptions of benefits and hurdles, and future expectations. CONCLUSIONS: The survey findings provide valuable information on the current state of the science of TGx applications and identify key areas in which TGx will have an impact as well as the key hurdles in applying TGx data to address issues. The findings serve as a public resource to facilitate discussions on the focus of future TGx efforts to ensure that a maximal benefit can be obtained from toxicogenomic studies.
format Text
id pubmed-2920921
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher National Institute of Environmental Health Sciences
record_format MEDLINE/PubMed
spelling pubmed-29209212010-08-13 Current and Future Applications of Toxicogenomics: Results Summary of a Survey from the HESI Genomics State of Science Subcommittee Pettit, Syril des Etages, Shelley Ann Mylecraine, Louis Snyder, Ronald Fostel, Jennifer Dunn, Robert T. Haymes, Kenneth Duval, Manuel Stevens, James Afshari, Cynthia Vickers, Alison Environ Health Perspect Research BACKGROUND: In spite of the application of toxicogenomic (TGx) data to the field of toxicology for the past 10 years, the broad implementation and full impact of TGx for chemical and drug evaluation to improve decision making within organizations and by policy makers has not been achieved. OBJECTIVES: The goal of the Health and Environmental Sciences Institute (HESI) Committee on the Application of Genomics to Mechanism-based Risk Assessment was to construct and summarize a multisector survey, addressing key issues and perspectives on the current and future practical uses and challenges of implementing TGx data to facilitate discussions for decision making within organizations and by policy makers. METHODS: An online survey to probe the current status and future challenges facing the field of TGx for drug and chemical evaluation in experimental and nonclinical models was taken by scientists and scientific decision/policy makers actively engaged in the field of TGx within industrial, academic, and regulatory sectors of the United States, Europe, and Japan. For this survey, TGx refers specifically to the analysis of gene expression responses to evaluate xenobiotic exposure in experimental and preclinical models. RESULTS: The survey results are summarized from questions covering broad areas including technology used, organizational capacity and resource allocation, experimental approaches, data storage and exchange, perceptions of benefits and hurdles, and future expectations. CONCLUSIONS: The survey findings provide valuable information on the current state of the science of TGx applications and identify key areas in which TGx will have an impact as well as the key hurdles in applying TGx data to address issues. The findings serve as a public resource to facilitate discussions on the focus of future TGx efforts to ensure that a maximal benefit can be obtained from toxicogenomic studies. National Institute of Environmental Health Sciences 2010-07 2010-01-25 /pmc/articles/PMC2920921/ /pubmed/20100679 http://dx.doi.org/10.1289/ehp.0901501 Text en http://creativecommons.org/publicdomain/mark/1.0/ Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, ?Reproduced with permission from Environmental Health Perspectives?); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright.
spellingShingle Research
Pettit, Syril
des Etages, Shelley Ann
Mylecraine, Louis
Snyder, Ronald
Fostel, Jennifer
Dunn, Robert T.
Haymes, Kenneth
Duval, Manuel
Stevens, James
Afshari, Cynthia
Vickers, Alison
Current and Future Applications of Toxicogenomics: Results Summary of a Survey from the HESI Genomics State of Science Subcommittee
title Current and Future Applications of Toxicogenomics: Results Summary of a Survey from the HESI Genomics State of Science Subcommittee
title_full Current and Future Applications of Toxicogenomics: Results Summary of a Survey from the HESI Genomics State of Science Subcommittee
title_fullStr Current and Future Applications of Toxicogenomics: Results Summary of a Survey from the HESI Genomics State of Science Subcommittee
title_full_unstemmed Current and Future Applications of Toxicogenomics: Results Summary of a Survey from the HESI Genomics State of Science Subcommittee
title_short Current and Future Applications of Toxicogenomics: Results Summary of a Survey from the HESI Genomics State of Science Subcommittee
title_sort current and future applications of toxicogenomics: results summary of a survey from the hesi genomics state of science subcommittee
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920921/
https://www.ncbi.nlm.nih.gov/pubmed/20100679
http://dx.doi.org/10.1289/ehp.0901501
work_keys_str_mv AT pettitsyril currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee
AT desetagesshelleyann currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee
AT mylecrainelouis currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee
AT snyderronald currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee
AT fosteljennifer currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee
AT dunnrobertt currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee
AT haymeskenneth currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee
AT duvalmanuel currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee
AT stevensjames currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee
AT afsharicynthia currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee
AT vickersalison currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee